Fryklund, Linda
23  Ergebnisse:
Personensuche X
?
1

Biosimilar erythropoiesis-stimulating agents and the risk o..:

Arnlind, Marianne Heibert ; Fryklund, Linda ; Vitols, Sigurd.
European Journal of Clinical Pharmacology.  72 (2016)  10 - p. 1161-1169 , 2016
 
?
2

Is the decision on the use of biosimilar growth hormone bas..:

Fryklund, Linda ; Ritzén, Martin ; Bertilsson, Göran.
European Journal of Clinical Pharmacology.  70 (2014)  5 - p. 509-517 , 2014
 
?
4

Exon 3-Deleted/Full-Length Growth Hormone Receptor Polymorp..:

Audí, Laura ; Esteban, Cristina ; Carrascosa, Antonio...
The Journal of Clinical Endocrinology & Metabolism.  91 (2006)  12 - p. 5038-5043 , 2006
 
?
7

A Novel Dysfunctional Growth Hormone Variant (Ile179Met) Ex..:

Lewis, Mark D. ; Horan, Martin ; Millar, David S....
The Journal of Clinical Endocrinology & Metabolism.  89 (2004)  3 - p. 1068-1075 , 2004
 
?
8

Changes in Free Rather Than Total Insulin-Like Growth Facto..:

Yuen, Kevin ; Frystyk, Jan ; Umpleby, Margot..
The Journal of Clinical Endocrinology & Metabolism.  89 (2004)  8 - p. 3956-3964 , 2004
 
?
9

The Effects of Short-Term Administration of Two Low DosesVe..:

Yuen, Kevin ; Ong, Ken ; Husbands, Sandra...
The Journal of Clinical Endocrinology & Metabolism.  87 (2002)  5 - p. 1989-1995 , 2002
 
?
11

Characterisation of a secreted form of recombinant derived ..:

Gellerfors, Pär ; Eketorp, Gunilla ; Fhölenhag, Karin...
Journal of Pharmaceutical and Biomedical Analysis.  7 (1989)  2 - p. 173-183 , 1989
 
?
12

Biological characterization of purified native 20-kDa human..:

Kostyo, Jack L. ; Skottner, Anna ; Brostedt, Peter...
Biochimica et Biophysica Acta (BBA) - General Subjects.  925 (1987)  3 - p. 314-324 , 1987
 
1-15